CLX: Hold + Reduce with a $65.39 price target

Capital earns more than at peers, but capital spending changes the cash picture.

Target for 2027-09-15: $65.39 USD, -25.5% versus the $87.76 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.

Over 1 year (2025-09-12 to 2026-09-11), price changed -28.9% and trailing EPS changed -28.3%. A wider gap changes the earnings multiple; it does not establish fair value.

Return on invested capital: 23.1% for CLX, against 7.6% across 12 comparable peers.

The latest quarterly operating margin was 52.5%, +31.3 percentage points from a year earlier. The full report separates sales growth from margin changes.

Operating cash covers 1.04 times profit, but cash after capital spending covers 0.69 times. Cash generation is stronger before the investment bill is paid.

Revenue changed -2.0% from the same quarter last year, through 2026-06-30. The previous quarter’s year-on-year change was +0.1%.

Watch whether cash after capital spending closes the gap with profit. It currently covers 0.69 times profit over four quarters.

Compare the next results with the trailing margin of 24.7% and the annual-history median of 11.1%. A historical median is context, not a forecast.

Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.

Starting annual sales growth: -1.39%.

Long-term operating margin: 13.85%.

Review recorded on 2026-09-16. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.